Literature DB >> 34525358

NIR light-responsive bacteria with live bio-glue coatings for precise colonization in the gut.

Meihui Cui1, Tao Sun2, Shubin Li3, Huizhuo Pan1, Jing Liu1, Xinyu Zhang1, Lianyue Li1, Shanshan Li4, Chunyang Wei4, Chengzhuang Yu4, Chun Yang1, Ning Ma1, Binglin Ma1, Shenjunjie Lu1, Jin Chang1, Weiwen Zhang2, Hanjie Wang5.   

Abstract

Recombinant bacterial colonization plays an indispensable role in disease prevention, alleviation, and treatment. Successful application mainly depends on whether bacteria can efficiently spatiotemporally colonize the host gut. However, a primary limitation of existing methods is the lack of precise spatiotemporal regulation, resulting in uncontrolled methods that are less effective. Herein, we design upconversion microgels (UCMs) to convert near-infrared light (NIR) into blue light to activate recombinant light-responsive bacteria (Lresb) in vivo, where autocrine "functional cellular glues" made of adhesive proteins assist Lresb inefficiently colonizing the gut. The programmable engineering platform is further developed for the controlled and effective colonization of Escherichia coli Nissle 1917 (EcN) in the gut. The colonizing bacteria effectively alleviate DSS-induced colitis in mice. We anticipate that this approach could facilitate the clinical application of engineered microbial therapeutics to accurately and effectively regulate host health.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  colonization; engineering bacteria; optogenetics

Mesh:

Substances:

Year:  2021        PMID: 34525358     DOI: 10.1016/j.celrep.2021.109690

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  3 in total

1.  Computational Methods for the Design of Recombinase Logic Circuits with Adaptable Circuit Specifications.

Authors:  Ana Zúñiga; Jérôme Bonnet; Sarah Guiziou
Journal:  Methods Mol Biol       Date:  2023

Review 2.  Emerging strategies for engineering Escherichia coli Nissle 1917-based therapeutics.

Authors:  Jason P Lynch; Lisa Goers; Cammie F Lesser
Journal:  Trends Pharmacol Sci       Date:  2022-02-26       Impact factor: 17.638

Review 3.  Native and Engineered Probiotics: Promising Agents against Related Systemic and Intestinal Diseases.

Authors:  Haokun Shen; Zitong Zhao; Zengjue Zhao; Yuyi Chen; Linghua Zhang
Journal:  Int J Mol Sci       Date:  2022-01-06       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.